Compile Data Set for Download or QSAR
Report error Found 117 of ki for UniProtKB: Q14289
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286349(US9518060, Example K7 | US11220518, Ex. No. K7 | U...)
Affinity DataKi:  0.165nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286350(US9518060, Example K8 | US11220518, Ex. No. K8 | U...)
Affinity DataKi:  0.181nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286348(US9518060, Example K6 | US11220518, Ex. No. K6 | U...)
Affinity DataKi:  0.376nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286347(US9518060, Example K5 | US11220518, Ex. No. K5 | U...)
Affinity DataKi:  0.683nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286345(US9518060, Example K3 | US11220518, Ex. No. K3 | U...)
Affinity DataKi:  0.912nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286246(5-{[(8S)-6,8-dimethyl-6,9-diazaspiro[4.5]dec-9-yl]...)
Affinity DataKi:  1.01nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286343(N-(2-ethoxy-5-fluoropyrimidin-4-yl)-6,6-dimethyl-5...)
Affinity DataKi:  1.12nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286320(US9518060, Example J6)
Affinity DataKi:  1.17nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM418606(N-[3-({[2-anilino-5- (trifluoromethyl)pyrimidin-4-...)
Affinity DataKi:  1.20nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50318884(CHEMBL1084546 | CHEMBL2430359 | N-methyl-N-(3-((2-...)
Affinity DataKi:  1.5nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286270(US9518060, Example E2 | US11220518, Ex. No. E2 | U...)
Affinity DataKi:  1.64nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286377(US9518060, Example L4 | US11220518, Ex. No. L4 | U...)
Affinity DataKi:  1.71nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286310(N-(5-fluoro-2-propylpyrimidin-4-yl)-6,6-dimethyl-5...)
Affinity DataKi:  1.73nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286260(US9518060, Example B3 | US11220518, Ex. No. B3 | U...)
Affinity DataKi:  2.03nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286327(N-[5-fluoro-2-(methoxymethyl)pyrimidin-4-yl]-6,6-d...)
Affinity DataKi:  2.10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286344(US9518060, Example K2 | US11220518, Ex. No. K2 | U...)
Affinity DataKi:  2.11nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50653104(CHEMBL5722987)
Affinity DataKi:  2.30nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286264(US9518060, Example B6 | US11220518, Ex. No. B6 | U...)
Affinity DataKi:  2.43nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50653106(CHEMBL5722946)
Affinity DataKi:  2.60nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286316(US9518060, Example J3)
Affinity DataKi:  2.63nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286227(N4-(6,6-dimethyl-5-{[(2S)-2,4,5,5-tetramethylpiper...)
Affinity DataKi:  2.69nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286346(US9518060, Example K4 | US11220518, Ex. No. K4 | U...)
Affinity DataKi:  3.33nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286244(US9518060, Example A8 | US11220518, Ex. No. A8 | U...)
Affinity DataKi:  3.39nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50269948(PF-228 | 6-(4-(3-(methylsulfonyl)benzylamino)-5-(t...)
Affinity DataKi:  3.60nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286311(US9518060, Example I2 | US11220518, Ex. No. I2 | U...)
Affinity DataKi:  3.67nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286242(US9518060, Example A7 | US11220518, Ex. No. A7 | U...)
Affinity DataKi:  3.81nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286239(US9518060, Example A5 | US11220518, Ex. No. A5 | U...)
Affinity DataKi:  3.95nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286380(N-(4-ethoxypyrimidin-2-yl)-6,6-dimethyl-5-{[(2S,5R...)
Affinity DataKi:  4.24nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286257(N2-ethyl-5-fluoro-N4-(5-{[(2S,5R)-4-(3-methoxyprop...)
Affinity DataKi:  5.09nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286267(N-(2-ethyl-5-fluoropyrimidin-4-yl)-6,6-dimethyl-5-...)
Affinity DataKi:  5.43nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM418817(US10450297, Example 317 | US10450297, Example 318 ...)
Affinity DataKi:  6.30nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286318(US9518060, Example J5 | US11220518, Ex. No. J5 | U...)
Affinity DataKi:  6.43nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286279(US9518060, Example H3 | US11220518, Ex. No. H3 | U...)
Affinity DataKi:  7.21nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50246060(CHEMBL472212 | N-methyl-N-(2-((2-(2-oxoindolin-5-y...)
Affinity DataKi:  8nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50653108(CHEMBL5722981)
Affinity DataKi:  8.40nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286317(US9518060, Example J4 | US11220518, Ex. No. J4 | U...)
Affinity DataKi:  8.64nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286231(US9518060, Example A2 | US11780853, Example A2)
Affinity DataKi:  8.75nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM50653107(CHEMBL5722989)
Affinity DataKi:  9.70nMAssay Description:Inhibition of full-length PYK2 (unknown origin) with C-terminal NanoLuc-fusion expressed in HEK293T cells by NanoBRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286245(US9518060, Example A9 | US11220518, Ex. No. A9 | U...)
Affinity DataKi:  9.73nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286273(2-((5S)-4-{[3-[(2-ethyl-5-fluoropyrimidin-4-yl)ami...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286384(5-{[(2S,5R)-2,5-dimethyl-4-(tetrahydro-2H-pyran-4-...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286385(US9518060, Example N3 | US9518060, Example N2 | US...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286368(US9518060, Example K24 | US9518060, Example K23 | ...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286330(US9518060, Example J10 | US11220518, Ex. No. J10 |...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286331(US9518060, Example J11 | US11220518, Ex. No. J11 |...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286332(US9518060, Example J12 | US11220518, Ex. No. J12 |...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286335(US9518060, Example J13 | US11220518, Ex. No. J13 |...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286340(US9518060, Example J15 | US11220518, Ex. No. J15 |...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286362(US9518060, Example K19 | US11220518, Ex. No. K19 |...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Pfizer

US Patent
LigandPNGBDBM286365(5-{[(2S,5R)-2,5-dimethyl-4-(tetrahydro-2H-pyran-4-...)
Affinity DataKi: <10nMpH: 7.4Assay Description:Protein Kinase C beta 2 (PKCβII) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

Displayed 1 to 50 (of 117 total ) | Next | Last >>
Jump to: